Optiver Holding B.V. Sanofi Transaction History

Optiver Holding B.V.

$3.01 Billion
Q4 2024

A detailed history of Optiver Holding B.V. transactions in Sanofi stock. As of the latest transaction made, Optiver Holding B.V. holds 63,605 shares of SNY stock, worth $3.46 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

63,605

Previous 487,234 86.95%

Holding current value

$3.46 Million

Previous $28.1 Million 89.08%

% of portfolio

0.1%

Previous 0.72%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$45.89 - $57.31 $19.4 Million - $24.3 Million	-423,629 Reduced 86.95%	63,605 $3.07 Million
Q3 2024 Nov 14, 2024	BUY	$48.54 - $58.53 $23.7 Million - $28.5 Million	487,234 New	487,234 $28.1 Million
Q3 2023 Nov 13, 2023	SELL	$50.95 - $55.2 $24.6 Million - $26.7 Million	-483,601 Reduced 67.48%	233,019 $12.5 Million
Q2 2023 Aug 10, 2023	BUY	$50.45 - $57.18 $15.6 Million - $17.7 Million	309,649 Added 76.09%	716,620 $38.6 Million
Q1 2023 May 11, 2023	BUY	$45.86 - $54.45 $13.9 Million - $16.5 Million	302,296 Added 288.79%	406,971 $22.1 Million
Q4 2022 Feb 10, 2023	BUY	$38.86 - $48.55 $1.16 Million - $1.44 Million	29,736 Added 39.68%	104,675 $5.07 Million
Q3 2022 Nov 14, 2022	BUY	$37.22 - $100.5 $26,054 - $70,350	700 Added 0.94%	74,939 $2.85 Million
Q2 2022 Aug 10, 2022	BUY	$48.99 - $57.46 $3.64 Million - $4.27 Million	74,239 New	74,239 $3.71 Million
Q1 2022 May 16, 2022	SELL	$48.48 - $53.65 $1.98 Million - $2.19 Million	-40,811 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$47.07 - $52.35 $92.4 Million - $103 Million	-1,962,698 Reduced 97.96%	40,811 $2.04 Million
Q1 2021 May 14, 2021	BUY	$45.46 - $50.51 $91.1 Million - $101 Million	2,003,509 New	2,003,509 $99.6 Million

Others Institutions Holding SNY

# of Institutions

800

Shares Held

266M

Call Options Held

1.82M

Put Options Held

1.64M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $137B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.

Account

Optiver Holding B.V. Sanofi Transaction History